Rejuveron Life Sciences is based in Zurich, Switzerland. It has raised $75M in total funding. Latest round: Series B.
Rejuveron Life Sciences is based in Zurich, Switzerland. Rejuveron Life Sciences has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2023. The round record for Rejuveron Life Sciences runs through 2023; nothing later has been disclosed. Investors on record include Catalio Capital Management, Apeiron Investment Group, Mubadala Capital. 3 distinct backers are named across the disclosed rounds.
We update the Rejuveron Life Sciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Zurich and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026